modafinil has been researched along with Lupus Erythematosus, Systemic in 1 studies
Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fatigue is a frequently reported and disabling symptom in patients with systemic lupus erythematosus (SLE)." | 5.62 | Improvement of lupus-associated fatigue with modafinil: Report of two cases. ( Korsten, P; Piantoni, S, 2021) |
| "Fatigue is a frequently reported and disabling symptom in patients with systemic lupus erythematosus (SLE)." | 1.62 | Improvement of lupus-associated fatigue with modafinil: Report of two cases. ( Korsten, P; Piantoni, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korsten, P | 1 |
| Piantoni, S | 1 |
1 other study available for modafinil and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Improvement of lupus-associated fatigue with modafinil: Report of two cases.
Topics: Fatigue; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Modafinil; Quality of Life; Sev | 2021 |